Antiinflammatory potential of nano‐curcumin as an alternative therapeutic agent for the treatment of mild‐to‐moderate hospitalized COVID‐19 patients in a placebo‐controlled clinical trial
Ali Asadirad(Ahvaz Jundishapur University of Medical Sciences), Sajad Dehnavi(Ahvaz Jundishapur University of Medical Sciences), Azam Aminian(Ahvaz Jundishapur University of Medical Sciences), Roohangiz Nashibi(Ahvaz Jundishapur University of Medical Sciences), Mahvash Sadeghi(Mashhad University of Medical Sciences), Ata Ghadiri(Ahvaz Jundishapur University of Medical Sciences), Ali Khodadadi(Ahvaz Jundishapur University of Medical Sciences)
Cited by 51
Related Papers
Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways
|Clinical Reviews in Allergy & Immunology|2020|362
Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases
|Inflammopharmacology|2023|139
The implications of exosomes in pregnancy: emerging as new diagnostic markers and therapeutics targets
|Cell Communication and Signaling|2022|122
Targeting AMPK by Statins: A Potential Therapeutic Approach
|Drugs|2021|100
Statins and autoimmunity: State-of-the-art
|Pharmacology & Therapeutics|2020|73